Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Understanding Neurocognition in Youth with Type 1 Diabetes (UNYT1D) Biostatistics Research Center (BRC)
Helgeson, E. S. (PI), Dai, B. (CoI), Eaton, A. (CoI), Eberly, L. (CoI), Hou, J. (CoI), Reilly, C. S. (CoI), Zhang, L. (CoI), Bohara, K. D. (Other Role), Burns, A. A. C. (Other Role), Croal, M. E. (Other Role), Eckroth, K. (Other Role), Krum, E. (Other Role), Lindberg, S. M. (Other Role), Meger, S. M. (Other Role), Mitchell, B. (Other Role), Nordwall, J. A. (Other Role), Schoenecker, R. W. (Other Role), Steichen, E. B. (Other Role), Voelker, H. T. (Other Role), Walski, J. M. (Other Role) & Zhang, R. (Other Role)
NATIONAL INSTITUTES OF HEALTH (NIH)
8/15/24 → 6/30/25
Project: Research project
-
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19
for the STRIVE Network and TICO Trial Study Group, Dec 2025, In: BMC infectious diseases. 25, 1, 67.Research output: Contribution to journal › Article › peer-review
Open Access -
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
The ITAC (INSIGHT 013) Study Group, Feb 5 2022, In: The Lancet. 399, 10324, p. 530-540 11 p.Research output: Contribution to journal › Article › peer-review
Open Access58 Scopus citations -
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors
Higgs, E. S., Gayedyu-Dennis, D., Fischer, W. A., Nason, M., Reilly, C., Beavogui, A. H., Aboulhab, J., Nordwall, J., Lobbo, P., Wachekwa, I., Cao, H., Cihlar, T., Hensley, L. & Lane, H. C., Nov 15 2021, In: Clinical Infectious Diseases. 73, 10, p. 1849-1856 8 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
A randomized, controlled trial of Ebola virus disease therapeutics
PALM Writing Group, Dec 12 2019, In: New England Journal of Medicine. 381, 24, p. 2293-2303 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1228 Scopus citations -
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
for the INSIGHT START Study Group, Mar 2019, In: Hepatology. 69, 3, p. 1135-1150 16 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations